{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=celecoxib+%28Celebrex%29", "query": { "intervention": "celecoxib (Celebrex)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 177, "total_pages": 18, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=celecoxib+%28Celebrex%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-01T16:20:38.032Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00638807", "title": "Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 388, "start_date": "2003-12", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Buena Park, California • Denver, Colorado + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Buena Park", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Longwood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00638807" }, { "nct_id": "NCT02160301", "title": "Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Post Operative Pain Control" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2017-11", "completion_date": "2019-12", "has_results": false, "last_update_posted_date": "2017-05-19", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02160301" }, { "nct_id": "NCT00538031", "title": "Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fallopian Tube Cancer", "Peritoneal Cavity Cancer", "Recurrent Ovarian Epithelial Cancer" ], "interventions": [ { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 52, "start_date": "2003-12-22", "completion_date": "2019-09-13", "has_results": true, "last_update_posted_date": "2023-04-21", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 2, "location_summary": "Duarte, California • Pasadena, California", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00538031" }, { "nct_id": "NCT04015908", "title": "A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Opioid Use" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Percocet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2019-08-01", "completion_date": "2023-01-31", "has_results": true, "last_update_posted_date": "2024-07-08", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04015908" }, { "nct_id": "NCT00620867", "title": "Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "Ibuprofen", "type": "DRUG" }, { "name": "celecoxib", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 393, "start_date": "2002-10", "completion_date": "2003-03", "has_results": false, "last_update_posted_date": "2021-02-21", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 33, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Anaheim, California + 30 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00620867" }, { "nct_id": "NCT04469530", "title": "Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "Sirolimus", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 55, "start_date": "2020-09-16", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 5, "location_summary": "Atlanta, Georgia • St Louis, Missouri • Pittsburgh, Pennsylvania + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04469530" }, { "nct_id": "NCT00136487", "title": "Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 85, "start_date": "2002-10", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2009-12-09", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 9, "location_summary": "Hartford, Connecticut • Boston, Massachusetts • Concord, Massachusetts + 3 more", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00136487" }, { "nct_id": "NCT00081263", "title": "Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cervical Carcinoma", "Cervical Intraepithelial Neoplasia Grade 2/3", "Stage 0 Cervical Cancer" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 130, "start_date": "2005-06", "completion_date": null, "has_results": true, "last_update_posted_date": "2017-09-15", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 43, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Lewes, Delaware + 32 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lewes", "state": "Delaware" }, { "city": "Newark", "state": "Delaware" }, { "city": "Urbana", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00081263" }, { "nct_id": "NCT00970502", "title": "Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cancer of the Pharynx", "Cancer of the Larynx", "Cancer of the Neck", "Paranasal Sinus Neoplasms", "Cancer of the Head" ], "interventions": [ { "name": "erlotinib + celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnny Kao", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2007-02", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2017-04-10", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00970502" }, { "nct_id": "NCT03818919", "title": "Nonopioid Analgesia After Rotator Cuff Repair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rotator Cuff Tear" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diazepam", "type": "DRUG" }, { "name": "Hydrocodone-Acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2019-01-22", "completion_date": "2020-12-31", "has_results": true, "last_update_posted_date": "2024-04-02", "last_synced_at": "2026-10-01T16:20:38.032Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03818919" } ] }